Tatu Rojalin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatu Rojalin has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Randy Patrick Carney
Department of Biomedical Engineering, University of California, Davis, CA, USA
6 shared publications Ruiwu Liu
Department of Biochemistry and Molecular Medicine, UC Davis NCI-designated Comprehensive Cancer Center, University of California Davis, Sacramento, California 95817, United States
3 shared publicationsAlisha Knudson
Department of Biochemistry and Molecular Medicine School of Medicine University of California Davis Sacramento CA 95817 USA
2 shared publicationsAnchaleena James
Department of Biomedical Engineering, University of California, Davis, United States
2 shared publications- Anthony Valenzuela
Department of Molecular Biosciences, University of California, Davis, United States
2 shared publications - Keith J. Bein
University of California, Davis
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 227, 107693
Multimodal deep learning for wound healing prediction
- 22 October 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 227, 107693
Open AccessMultimodal deep learning for wound healing prediction
- Open Access
- 27 January 2026
- Published by Elsevier in Environmental Pollution
- Vol. 393, 127730
Spatial and spectral mapping of traffic-related nanoparticles in hippocampal subregions of an Alzheimer disease model
- 27 January 2026
- Published by Elsevier in Environmental Pollution
- Vol. 393, 127730
Open AccessSpatial and spectral mapping of traffic-related nanoparticles in hippocampal subregions of an Alzheimer disease model
- Open Access
Spatial and spectral mapping of traffic-related air pollution (TRAP) nanoparticles in relation to plaques and inflammatory markers in an Alzheimer disease model
Chronic exposure to traffic-related air pollution (TRAP) is linked to increased risk of neurodegenerative diseases, including Alzheimer disease (AD). Ultrafine particulate matter (UFPM) is a suspected driver of TRAP neurotoxicity, but its spatial interactions with AD pathology remain poorly defined. We investigated the distribution, composition, and pathological context of TRAP-derived UFPM in the hippocampus of TgF344-AD rats chronically exposed to TRAP or filtered air (FA) for 14 months. Using a multimodal imaging workflow that combines enhanced darkfield hyperspectral imaging (EDF-HSI) with confocal immunofluorescence for microglia (CD68/Iba1) and amyloid beta (Aβ) plaques (Thioflavin S), we mapped the localization and spectral properties of UFPM in situ. UFPM accumulation was elevated in TRAP-exposed females, suggesting sex-specific vulnerability in blood-brain barrier (BBB) permeability or particle retention. Particles near plaques showed red-shifted spectral signatures, consistent with biochemical transformation. Dimension reduction revealed clustering of particle spectra by TRAP exposure and plaque proximity. However, UFPM was rarely found within plaques or microglia, implying indirect neuroimmune modulation. These findings highlight a novel spatial and spectral imaging approach for characterizing environmental nanoparticle interactions in the brain and suggest that chronic TRAP exposure may influence AD-related inflammation and pathology in a sex-and region-dependent manner. Synopsis This study shows that chronic traffic-related air pollution alters ultrafine particulate matter deposition and neuroinflammation in a rodent Alzheimer model, revealing region- and sex-specific vulnerability in the brain’s response to environmental exposure.
Open AccessSpatial and spectral mapping of traffic-related air pollution (TRAP) nanoparticles in relation to plaques and inflammatory markers in an Alzheimer disease model
Chronic exposure to traffic-related air pollution (TRAP) is linked to increased risk of neurodegenerative diseases, including Alzheimer disease (AD). Ultrafine particulate matter (UFPM) is a suspected driver of TRAP neurotoxicity, but its spatial interactions with AD pathology remain poorly defined. We investigated the distribution, composition, and pathological context of TRAP-derived UFPM in the hippocampus of TgF344-AD rats chronically exposed to TRAP or filtered air (FA) for 14 months. Using a multimodal imaging workflow that combines enhanced darkfield hyperspectral imaging (EDF-HSI) with confocal immunofluorescence for microglia (CD68/Iba1) and amyloid beta (Aβ) plaques (Thioflavin S), we mapped the localization and spectral properties of UFPM in situ. UFPM accumulation was elevated in TRAP-exposed females, suggesting sex-specific vulnerability in blood-brain barrier (BBB) permeability or particle retention. Particles near plaques showed red-shifted spectral signatures, consistent with biochemical transformation. Dimension reduction revealed clustering of particle spectra by TRAP exposure and plaque proximity. However, UFPM was rarely found within plaques or microglia, implying indirect neuroimmune modulation. These findings highlight a novel spatial and spectral imaging approach for characterizing environmental nanoparticle interactions in the brain and suggest that chronic TRAP exposure may influence AD-related inflammation and pathology in a sex-and region-dependent manner. Synopsis This study shows that chronic traffic-related air pollution alters ultrafine particulate matter deposition and neuroinflammation in a rodent Alzheimer model, revealing region- and sex-specific vulnerability in the brain’s response to environmental exposure.
- Open Access
- 8 August 2023
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 1 (8) , 725-737
A Multi-Fluorophore Staining Scheme for Identification and Quantification of Vomocytosis
Vomocytosis is a process by which fungal pathogens, for instance, Cryptococcus neoformans (CN), escape from the digestive phagolysosome of phagocytic cells after ingestion. Interestingly, this expulsion leaves both the pathogen and phagocyte unharmed, and is believed to be an important mechanism by which CNs disseminate throughout infected hosts. This phenomenon was discovered in 2006, and research to date has relied almost entirely on quantification via manual counting of vomocytosis events in time-lapse microscopy videos. This archaic method has the significant disadvantages of requiring excessive labor in manual analysis, limited throughput capabilities, and low accuracy due to subjectivity. Here, we present an alternative method to measure vomocytosis rates using a multi-fluorophore reporter system comprised of two in situ staining steps during infection and a flow cytometry readout. This approach overcomes the limitations of conventional time lapse microscopy methods, with key advantages of high throughput capability, simple procedural steps, and accurate objective readouts. This study rigorously characterizes this vomocytosis reporter system in CN-infected MΦ and DC cultures via fluorescence microscopy, confocal microscopy, and flow cytometry. Here, this fluorescent tool is used to observe differences in expulsion rates after phagosome-modifying drug treatments and additionally utilized to distinguish differences in biochemical compositions among fluorescence-activated cell sorted fungal populations via Raman spectroscopy. Furthermore, this reporter scheme is demonstrated to be adaptable for use in measuring potential biomaterial particle expulsion events. Ultimately, the fluorescent reporter system presented here provides a universal tool for vomocytosis rate measurement of phagocytosed material. This facile approach opens the door to previously unfeasible types of vomocytosis-related studies such as high throughput treatment mechanistic screening and downstream characterization of expelled material.
- 8 August 2023
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 1 (8) , 725-737
Open AccessA Multi-Fluorophore Staining Scheme for Identification and Quantification of Vomocytosis
Vomocytosis is a process by which fungal pathogens, for instance, Cryptococcus neoformans (CN), escape from the digestive phagolysosome of phagocytic cells after ingestion. Interestingly, this expulsion leaves both the pathogen and phagocyte unharmed, and is believed to be an important mechanism by which CNs disseminate throughout infected hosts. This phenomenon was discovered in 2006, and research to date has relied almost entirely on quantification via manual counting of vomocytosis events in time-lapse microscopy videos. This archaic method has the significant disadvantages of requiring excessive labor in manual analysis, limited throughput capabilities, and low accuracy due to subjectivity. Here, we present an alternative method to measure vomocytosis rates using a multi-fluorophore reporter system comprised of two in situ staining steps during infection and a flow cytometry readout. This approach overcomes the limitations of conventional time lapse microscopy methods, with key advantages of high throughput capability, simple procedural steps, and accurate objective readouts. This study rigorously characterizes this vomocytosis reporter system in CN-infected MΦ and DC cultures via fluorescence microscopy, confocal microscopy, and flow cytometry. Here, this fluorescent tool is used to observe differences in expulsion rates after phagosome-modifying drug treatments and additionally utilized to distinguish differences in biochemical compositions among fluorescence-activated cell sorted fungal populations via Raman spectroscopy. Furthermore, this reporter scheme is demonstrated to be adaptable for use in measuring potential biomaterial particle expulsion events. Ultimately, the fluorescent reporter system presented here provides a universal tool for vomocytosis rate measurement of phagocytosed material. This facile approach opens the door to previously unfeasible types of vomocytosis-related studies such as high throughput treatment mechanistic screening and downstream characterization of expelled material.
- Open Access
- 4 August 2022
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 22 (17) , 6866-6876
Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment
Immune checkpoint blockade (ICB) therapy has revolutionized clinical oncology. However, the efficacy of ICB therapy is limited by the ineffective infiltration of T effector (Teff) cells to tumors and the immunosuppressive tumor microenvironment (TME). Here, we report a programmable tumor cells/Teff cells bispecific nano-immunoengager (NIE) that can circumvent these limitations to improve ICB therapy. The peptidic nanoparticles (NIE-NPs) bind tumor cell surface α3β1 integrin and undergo in situ transformation into nanofibrillar network nanofibers (NIE-NFs). The prolonged retained nanofibrillar network at the TME captures Teff cells via the activatable α4β1 integrin ligand and allows sustained release of resiquimod for immunomodulation. This bispecific NIE eliminates syngeneic 4T1 breast cancer and Lewis lung cancer models in mice, when given together with anti-PD-1 antibody. The in vivo structural transformation-based supramolecular bispecific NIE represents an innovative class of programmable receptor-mediated targeted immunotherapeutics to greatly enhance ICB therapy against cancers.
- 4 August 2022
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 22 (17) , 6866-6876
Open AccessProgrammable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment
Immune checkpoint blockade (ICB) therapy has revolutionized clinical oncology. However, the efficacy of ICB therapy is limited by the ineffective infiltration of T effector (Teff) cells to tumors and the immunosuppressive tumor microenvironment (TME). Here, we report a programmable tumor cells/Teff cells bispecific nano-immunoengager (NIE) that can circumvent these limitations to improve ICB therapy. The peptidic nanoparticles (NIE-NPs) bind tumor cell surface α3β1 integrin and undergo in situ transformation into nanofibrillar network nanofibers (NIE-NFs). The prolonged retained nanofibrillar network at the TME captures Teff cells via the activatable α4β1 integrin ligand and allows sustained release of resiquimod for immunomodulation. This bispecific NIE eliminates syngeneic 4T1 breast cancer and Lewis lung cancer models in mice, when given together with anti-PD-1 antibody. The in vivo structural transformation-based supramolecular bispecific NIE represents an innovative class of programmable receptor-mediated targeted immunotherapeutics to greatly enhance ICB therapy against cancers.
- 23 May 2017
- Published by Wiley in Advanced Biosystems
- Vol. 1 (5)
Biosensors: Targeting Tumor‐Associated Exosomes with Integrin‐Binding Peptides (Adv. Biosys. 5/2017)
- 23 May 2017
- Published by Wiley in Advanced Biosystems
- Vol. 1 (5)
Biosensors: Targeting Tumor‐Associated Exosomes with Integrin‐Binding Peptides (Adv. Biosys. 5/2017)
- 3 April 2017
- Published by Wiley in Advanced Biosystems
- Vol. 1 (5)
Targeting Tumor‐Associated Exosomes with Integrin‐Binding Peptides
All cells expel a variety of nanosized extracellular vesicles (EVs), including exosomes, with composition reflecting the cells' biological state. Cancer pathology is dramatically mediated by EV trafficking via key proteins, lipids, metabolites, and microRNAs. Recent proteomics evidence suggests that tumor‐associated exosomes exhibit distinct expression of certain membrane proteins, rendering those proteins as attractive targets for diagnostic or therapeutic application, yet it is not currently feasible to distinguish circulating EVs in complex biofluids according to their tissue of origin or state of disease. Here, peptide binding to tumor‐associated EVs via overexpressed membrane protein is demonstrated. It is found that SKOV‐3 ovarian tumor cells and their released EVs express α3β1 integrin, which can be targeted by the in‐house cyclic nonapeptide, LXY30. After measuring bulk SKOV‐3 EV association with LXY30 by flow cytometry, Raman spectral analysis of laser‐trapped single exosomes with LXY30‐dialkyne conjugate enables the differentiation of cancer‐associated exosomes from noncancer exosomes. Furthermore, the foundation for a highly specific detection platform for tumor‐EVs in solution with biosensor surface‐immobilized LXY30 is introduced. LXY30 not only exhibits high specificity and affinity to α3β1 integrin‐expressing EVs, but also reduces EV uptake into SKOV‐3 parent cells, demonstrating the possibility for therapeutic application.
- 3 April 2017
- Published by Wiley in Advanced Biosystems
- Vol. 1 (5)
Targeting Tumor‐Associated Exosomes with Integrin‐Binding Peptides
All cells expel a variety of nanosized extracellular vesicles (EVs), including exosomes, with composition reflecting the cells' biological state. Cancer pathology is dramatically mediated by EV trafficking via key proteins, lipids, metabolites, and microRNAs. Recent proteomics evidence suggests that tumor‐associated exosomes exhibit distinct expression of certain membrane proteins, rendering those proteins as attractive targets for diagnostic or therapeutic application, yet it is not currently feasible to distinguish circulating EVs in complex biofluids according to their tissue of origin or state of disease. Here, peptide binding to tumor‐associated EVs via overexpressed membrane protein is demonstrated. It is found that SKOV‐3 ovarian tumor cells and their released EVs express α3β1 integrin, which can be targeted by the in‐house cyclic nonapeptide, LXY30. After measuring bulk SKOV‐3 EV association with LXY30 by flow cytometry, Raman spectral analysis of laser‐trapped single exosomes with LXY30‐dialkyne conjugate enables the differentiation of cancer‐associated exosomes from noncancer exosomes. Furthermore, the foundation for a highly specific detection platform for tumor‐EVs in solution with biosensor surface‐immobilized LXY30 is introduced. LXY30 not only exhibits high specificity and affinity to α3β1 integrin‐expressing EVs, but also reduces EV uptake into SKOV‐3 parent cells, demonstrating the possibility for therapeutic application.